Live Breaking News & Updates on V Koneti Rao

Stay updated with breaking news from V koneti rao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pharming N : Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs) - Form 6-K -December 15, 2023 at 06:20 am EST

Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

. ....

United Kingdom , Noord Holland , United States , City Of , Gulbu Uzel , Ethan Metelenis , Anurag Relan , Heather Robertson , V Koneti Rao , Michael Levitan , Pharming Groupnv , Commission File Number , Pharming Group , Investor Relations Corporate Communications , Lifespring Life Sciences Communication , National Institutes Of Health , Exchange Commission , Drug Administration , Securities Exchange , National Institute Of Allergy , Senior Research Physician , Clinical Immunodeficiency Program , Vp Investor Relations Corporate Communications , Beth Israel Lahey Health , File Number , Exact Name ,

Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)

Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Noord Holland , City Of , United Kingdom , United States , Heather Robertson , Anurag Relan , Ethan Metelenis , Michael Levitan , V Koneti Rao , Gulbu Uzel , Lifespring Life Sciences Communication , National Institutes Of Health , Pharming Group , Drug Administration , Investor Relations Corporate Communications , Clinical Immunodeficiency Program , Exchange Commission , Senior Research Physician , Beth Israel Lahey Health , Vp Investor Relations Corporate Communications , National Institute Of Allergy , Pharming Groupnv , National Institute , Infectious Diseases , National Institutes , Primary Immune Deficiency Clinic ,

Pharming Group Announces Development Plans For Leniolisib For Additional Primary Immunodeficiencies (Pids)

Pharming Group Announces Development Plans For Leniolisib For Additional Primary Immunodeficiencies (Pids)
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , Noord Holland , United States , Anurag Relan , Michael Levitan , Gulbu Uzel , V Koneti Rao , Heather Robertson , Ethan Metelenis , Investor Relations Corporate Communications , Lifespring Life Sciences Communication , National Institutes Of Health , Pharming Groupnv , National Institute Of Allergy , Clinical Immunodeficiency Program , Senior Research Physician , Vp Investor Relations Corporate Communications , Pharming Group , Beth Israel Lahey Health , Drug Administration , Exchange Commission , National Institute , Infectious Diseases , National Institutes , Primary Immune Deficiency Clinic ,

Pharming Group N.V.: Pharming announces positive interim analysis data from open-label extension study of leniolisib in presentation at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition

V. Koneti Rao, MD, shared new evidence of long-term safety and hematologic response in patients who received leniolisib to treat APDS, a rare primary immunodeficiency Interim analysis demonstrated ....

National Institutes Of Health , United States , United Kingdom , City Of , Noord Holland , V Koneti Rao , Ethan Metelenis , Heather Robertson , Michael Levitan , Virgil Dalm , Dan Caley , Anurag Relan , Vp Investor Relations Corporate Communications , Drug Administration , Exchange Commission , Meeting Of The American Society Hematology , Prnewswire Pharming Groupnv , European Union , European Medicines Agency , Pharming Group , Lifespring Life Sciences Communication , Committee For Medicinal Products Human Use , Investor Relations Corporate Communications , Koneti Rao , Primary Immune Deficiency Clinic , National Institutes ,

Pharming announces positive interim analysis data from open-label extension study of leniolisib in presentation at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition

/PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces data, including new evidence, from an. ....

National Institutes Of Health , United States , United Kingdom , City Of , Noord Holland , V Koneti Rao , Ethan Metelenis , Heather Robertson , Michael Levitan , Virgil Dalm , Dan Caley , Anurag Relan , Vp Investor Relations Corporate Communications , Drug Administration , Exchange Commission , Meeting Of The American Society Hematology , Pharming Groupnv , European Union , European Medicines Agency , Pharming Group , Lifespring Life Sciences Communication , Committee For Medicinal Products Human Use , Investor Relations Corporate Communications , Koneti Rao , Primary Immune Deficiency Clinic , National Institutes ,